Ikarian Capital, LLC Bluebird Bio, Inc. Call Options Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 16, 2021	SELL	$18.04 - $22.09 $1.92 Million - $2.35 Million	-106,200 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$27.5 - $37.92 $1.96 Million - $2.7 Million	71,200 Added 203.43%	106,200 $4.6 Million
Q2 2020 Aug 14, 2020	SELL	$27.12 - $45.97 $949,200 - $1.61 Million	-35,000 Reduced 50.0%	35,000 $2.14 Million
Q1 2020 May 15, 2020	BUY	$26.16 - $63.5 $1.83 Million - $4.45 Million	70,000 New	70,000 $3.22 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $29.3M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.